Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 253.93 K151.9 K132.11 K408.56 K225.93 K 918.51 K Research & development ————— — Operating income -253.93 K-151.9 K-132.11 K-408.56 K-225.93 K -918.51 K Non-Operating Income, Total 403.73 K614.51 K629.95 K583.41 K287.4 K 2.12 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 403.73 K614.51 K629.95 K583.41 K287.4 K 2.12 M Unusual income/expense ————— — Pretax income 149.8 K462.62 K497.83 K174.84 K61.47 K 1.2 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 149.8 K462.62 K497.83 K174.84 K61.47 K 1.2 M Discontinued operations ————— — Net income 149.8 K462.62 K497.83 K174.84 K61.47 K 1.2 M Dilution adjustment 3.26 M614.51 K629.95 K—437.4 K — Preferred dividends 3.26 M614.51 K629.95 K—437.4 K — Diluted net income available to common stockholders 149.8 K462.62 K497.83 K174.84 K61.47 K 1.2 M Basic earnings per share (Basic EPS) 0.060.210.180.060.03 0.48 Diluted earnings per share (Diluted EPS) 0.060.210.180.060.03 0.48 Average basic shares outstanding 6.23 M7.09 M7.38 M7.52 M5.11 M — Diluted shares outstanding 10.63 M12.29 M12.85 M13.13 M8.27 M — EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —